Imagine watching your body change at two years old, developing non-cancerous tumors that wrap around your nerves, or facing a reality where you are the only person in your entire province diagnosed with a specific terminal genetic disorder. That isn't a plot for a medical drama. It's the daily reality for thousands of Canadians living with rare genetic conditions.
When we hear about rare diseases, we tend to treat them as medical curiosities. We look at the statistics and think they only happen to other people. But the reality of navigating life with a rare, highly visible, or profoundly expensive condition is less about the science and more about a brutal combination of social stigma and bureaucratic roadblocks. From Port Moody to Vancouver Island, British Columbians are speaking out about what it actually takes to survive a system that frequently fails to understand them.
The Invisible Weight of Highly Visible Conditions
Most people assume that getting a medical diagnosis brings clarity and relief. For many living with rare conditions, it actually marks the beginning of a lifelong battle against public perception. Consider Neurofibromatosis Type 1 (NF1). It affects roughly one in every 2,500 Canadians. NF1 causes tumors to grow uncontrollably along the nervous system. Because the condition is highly individualized, it looks completely different from one person to the next.
For individuals like Kirsten Anne, a Port Moody resident diagnosed when she was just a toddler, the tumors concentrated primarily across her back and torso. Growing up with a highly visible genetic differences meant that childhood wasn't just about managing symptoms; it was about enduring relentless playground bullying and cruelty. The names people call you when your body doesn't conform to standard expectations leave deep scars that linger long after childhood ends.
This is the hidden tax of living with a visible genetic difference. You aren't just managing scoliosis, potential vision loss, airway blockages, or an elevated risk of aggressive cancers like breast cancer. You're forced to constantly manage the comfort levels of the healthy people around you. You're stuck deciding whether to cover up, smile and deflect intrusive questions, or launch into a stressful medical lecture just to put a stranger at ease.
When Your Brain Fluid Costs One Million Dollars a Year
Social stigma is agonizing, but systemic institutional failure is outright dangerous. The intersection of rare genetic disorders and provincial healthcare infrastructure often creates a terrifying battleground over the price of human life.
Take the recent, high-stakes battle over Batten disease treatment on Vancouver Island. Neuronal ceroid lipofuscinosis Type 2 (known as CLN2 or Batten disease) is an exceptionally rare, fatal neurodegenerative disorder. It causes relentless daily seizures, progressive blindness, loss of mobility, and cognitive decline. There are fewer than 20 people in Canada living with it. Ten-year-old Charleigh Pollock is the only person in British Columbia with the condition.
Before receiving an innovative drug called Brineura, Charleigh endured more than 100 severe seizures every single day. Brineura isn't a cure, but it is a vital life-sustaining treatment. It's a specialized fluid infused directly into the brain to aggressively slow down the progression of the disease.
The catch? It costs roughly $1 million per year.
In mid-2025, the B.C. Ministry of Health abruptly pulled funding for Charleigh’s treatment. An independent expert review panel claimed the medication was no longer meeting the rigorous clinical metrics required to prove it was still working.
The decision triggered immediate outrage from international medical experts and the Batten Disease Support and Research Association. Leading neuroscientists pointed out a fatal flaw in the government's bureaucratic evaluation: "Time is neurons." Every single week a child with Batten disease goes without an infusion, irreplaceable brain cells die. Pulling the medication because a child isn't showing "enough" linear improvement isn't evidence-based care; advocates argued it felt more like controlled euthanasia.
Though intense public pressure and a letter signed by over a dozen global experts eventually forced the B.C. Health Ministry to reinstate Charleigh’s funding, the ordeal exposed a terrifying systemic truth. When you have an ultra-rare disease, your life is constantly at the mercy of bureaucratic committees using rigid, black-and-white formulas to evaluate highly complex, individual human bodies.
Moving Past Awareness to True Action
We don't need more vague "awareness months." We need structural changes to how rare diseases are managed, funded, and understood by the public. If you want to move beyond being a passive bystander and actually support the rare disease community, here's what needs to happen next:
- Rethink the Way You Look: If you see someone with visible physical differences, tumors, or mobility aids, stop staring. If you feel compelled to ask a question, ask yourself first if you’re doing it to satisfy your own curiosity or to actually help.
- Challenge Bureaucracy: Support organizations fighting for an updated, national rare disease strategy in Canada. Rigid provincial drug review processes shouldn't be shutting out international clinical specialists who understand these niche conditions far better than a general government panel.
- Support Adaptive Art and Advocacy: Many individuals living with chronic conditions channel their trauma into community initiatives and creative outlets. Seek out, fund, and elevate platforms where disabled and neurodivergent creators tell their own stories on their own terms.
The fight for rare disease dignity shouldn't depend on a family's ability to launch a massive media campaign or set up a GoFundMe page just to keep their child alive. It requires a collective refusal to look away when a medical reality feels too uncomfortable or too expensive to confront.
This video on rare disease policy advocacy provides critical context regarding how international medical experts and local communities rally to challenge provincial healthcare decisions.
